CheckMate 214 patient-reported outcomes: listening to our patients

Lancet Oncol. 2019 Feb;20(2):179-180. doi: 10.1016/S1470-2045(18)30790-3. Epub 2019 Jan 15.

Authors

Francesco Massari¹, Vincenzo Di Nunno²

Affiliations

¹ Division of Oncology, Policlinico Sant'Orsola-Malpighi Hospital, Bologna 40138, Italy. Electronic address: fmassari79@gmail.com.
² Division of Oncology, Policlinico Sant'Orsola-Malpighi Hospital, Bologna 40138, Italy.

PMID: 30658937
DOI: 10.1016/S1470-2045(18)30790-3

No abstract available

Publication types

Comment

MeSH terms

Carcinoma, Renal Cell*
Humans
Ipilimumab
Kidney Neoplasms*
Nivolumab
Patient Reported Outcome Measures
Sunitinib

Substances

Ipilimumab
Nivolumab
Sunitinib